Dow Up 0.76% Nasdaq Up 0.69%

Dendreon Corp. (DNDN)

-NasdaqGS
1.03 Down 0.01(0.96%) Oct 24, 3:59PM EDT
Prev Close:1.04
Open:1.04
Bid:N/A
Ask:1.09 x 100
1y Target Est:1.82
Beta:2.92
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:1.00 - 1.05
52wk Range:0.89 - 3.52
Volume:1,025,539
Avg Vol (3m):2,324,520
Market Cap:160.09M
P/E (ttm):N/A
EPS (ttm):-1.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
DNDNDown 0.96%160.09M
NWBODown 3.30%279.07M
PGNXUp 2.39%328.30M
SNYUp 0.92%141.76B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):0.55
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.72
Quarterly EPS Est (Sep-14) :-0.19
Mean Recommendation*:3.8
PEG Ratio (5 yr expected):-0.02

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dendreon Corporation, a biotechnology company, focuses on the discovery, development, and commercialization of novel therapeutics to enhance cancer treatment options for patients. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback